Laboratory capacity to detect antimicrobial resistance, 1998

Morbidity and Mortality Weekly Report

Volumn 48, Issue 51-52, 2000, Pages 1167-1171

  Moshar, P ^a   Hadler, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; ENTEROBACTERIACEAE; LABORATORY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PRACTICE GUIDELINE; STANDARD; STAPHYLOCOCCUS AUREUS;

DRUG RESISTANCE, MICROBIAL; ENTEROBACTERIACEAE; GUIDELINES; LABORATORIES; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS;

EID: 0034614297     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR 1997;46:624-6.
2. CDC. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR 1997;46:765-6.
3. CDC. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR 1997;46:813-5.
4. Smith T, Pearson M, Wilcox K, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;440:493-501.
5. National Nosocomial Infection Surveillance (NNIS) System. Report, data summary from January 1990-May 1999. Am J Infect Control 1999;27:520-32.
6. CDC. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR 1997;46:626-8,635-6.
7. National Committee for Clinical Laboratory Standards. Approved standard M7-A4: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
8. National Committee for Clinical Laboratory Standards. Approved standard M100-S8: performance standards for antimicrobial susceptibility testing. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1998.
9. National Committee for Clinical Laboratory Standards. Approved standard M100-S9: performance standards for antimicrobial susceptibility testing. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1999.
10. Tenover FC, Lancaster MV, Hill BC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998;36:2167.